Ian

FAQ About Ian

• What is Ian 's address?

  Ian is located at
  United Kingdom

• What is Ian 's job title?

  Ian is a
  Ian Cree is a pathologist, now working through his consultancy company, CanTech Ltd, providing advice on pathology and diagnostic technology. He is a visiting scientist to the Nuffield Department of Surgical Sciences University of Oxford on the WCT evidence mapping project, having recently retired from his previous post as Head of WHO Tumour Classification (WCT) Group and Head of the section of Evidence Synthesis and Classification, at the International Agency for Research on Cancer in Lyon, France. He is an Honorary Professor of Pathology at the Institute of Ophthalmology, part of University College London. He has previously held posts as the foundation Yvonne Carter Professor of Pathology at Warwick Medical School, Professor of Histopathology at the University of Portsmouth and Director of the Efficacy and Mechanism Evaluation (EME) programme for the UK National Institute of Health Research Evaluation Trials and Studies Coordinating Centre. Until April 2015 he was a member of the NICE Diagnostics Advisory Committee. He was the first Chair of the Inter-specialty Committee on Molecular Pathology for the Royal College of Pathologists, and subsequently chaired its Research Committee. Trained first in medicine, and then as a general pathologist with a PhD in immunology, Ian's research career has been based on investigating disease mechanisms to improve diagnosis and treatment, particularly for cancer. He has worked on personalised medicine for cancer since the late 1980s, and developed a number of molecular diagnostics methods for cancer diagnosis and management. He started the UK Early Cancer Detection Consortium, and its spin out company, PinPoint Data Science. He has published more than 300 papers, and 11 books. Specialties: Translational research management, Pathology, Molecular Pathology, Cancer Research, Ophthalmic histopathology Nuffield Department Of Surgical Sciences University Of Oxford

• What industry does Ian currently work in?

  Ian currently works in the
  Nuffield Department Of Surgical Sciences University Of Oxford

• What is Ian 's area of expertise?

  Ian specializes in
  Ian Cree is a pathologist, now working through his consultancy company, CanTech Ltd, providing advice on pathology and diagnostic technology. He is a visiting scientist to the Nuffield Department of Surgical Sciences University of Oxford on the WCT evidence mapping project, having recently retired from his previous post as Head of WHO Tumour Classification (WCT) Group and Head of the section of Evidence Synthesis and Classification, at the International Agency for Research on Cancer in Lyon, France. He is an Honorary Professor of Pathology at the Institute of Ophthalmology, part of University College London. He has previously held posts as the foundation Yvonne Carter Professor of Pathology at Warwick Medical School, Professor of Histopathology at the University of Portsmouth and Director of the Efficacy and Mechanism Evaluation (EME) programme for the UK National Institute of Health Research Evaluation Trials and Studies Coordinating Centre. Until April 2015 he was a member of the NICE Diagnostics Advisory Committee. He was the first Chair of the Inter-specialty Committee on Molecular Pathology for the Royal College of Pathologists, and subsequently chaired its Research Committee. Trained first in medicine, and then as a general pathologist with a PhD in immunology, Ian's research career has been based on investigating disease mechanisms to improve diagnosis and treatment, particularly for cancer. He has worked on personalised medicine for cancer since the late 1980s, and developed a number of molecular diagnostics methods for cancer diagnosis and management. He started the UK Early Cancer Detection Consortium, and its spin out company, PinPoint Data Science. He has published more than 300 papers, and 11 books. Specialties: Translational research management, Pathology, Molecular Pathology, Cancer Research, Ophthalmic histopathology

• Which languages does Ian speak? 

  Ian speaks the following languages:
  No languages available.

• Which industries has Ian previously worked in?   

  Ian has prior experience in the following industries:
  International Agency For Research On Cancer World Health Organization , Pinpoint Cancer , Nhs University Hospitals Coventry And Warwickshire Nhs Trust , Nihr Evaluation Studies And Trials Coordinating Centre , University Of Portsmouth , University Of Warwick , Nihr Evaluation Studies And Trials Coordinating Centre , Nalia Systems , Portsmouth Hospitals Hhs Trust , Cantech , Institute Of Opthalmology Ucl , University Of Dundee Medical School

• What is Ian ’s work experience?  

  Ian has the following professional experience:
  Nuffield Department Of Surgical Sciences University Of Oxford , Cantech , International Agency For Research On Cancer World Health Organization , Pinpoint Cancer , Coventry University , Nhs University Hospitals Coventry And Warwickshire Nhs Trust , Nihr Evaluation Studies And Trials Coordinating Centre , University Of Portsmouth , University Of Warwick , Nihr Evaluation Studies And Trials Coordinating Centre , Nalia Systems , University College London , Portsmouth Hospitals Hhs Trust , Cantech , Institute Of Opthalmology Ucl , University Of Dundee Medical School .

• How can I find Ian on LinkedIn?  

  You can view Ian ’s
  LinkedIn profile at LinkedIn URL.

• What are Ian ’s work email addresses?  

  Ian ’s work email addresses are
  [email protected] .

• What company does Ian work for?  

  Ian works at
  Nuffield Department Of Surgical Sciences University Of Oxford